Goldman Sachs cuts Booz Allen Hamilton stock to sell, target to $94

Published 28/05/2025, 10:56
Goldman Sachs cuts Booz Allen Hamilton stock to sell, target to $94

On Wednesday, Goldman Sachs downgraded Booz Allen Hamilton stock, listed on the New York Stock Exchange (NYSE:BAH), from a Neutral to a Sell rating, setting a new price target of $94.00. The stock, currently trading at $109.81, has declined 14.5% in the past week. The move reflects the firm’s expectations of limited revenue and earnings growth for the company in the medium term, despite its 12.4% revenue growth over the last twelve months.

Stifel analysts indicated that the downgrade was driven by anticipated pressures on federal civilian spending and shifting priorities within the Department of Defense (DoD). They believe these factors could lead to relatively flat revenue growth for Booz Allen Hamilton in the coming years. According to InvestingPro data, five analysts have recently revised their earnings estimates downward for the upcoming period.

The analysts also expressed concerns about potential risks to the company’s profit margins due to changes in contract structures. This assessment is based on the current trading values of Booz Allen Hamilton, which are 17 times the price-to-earnings (P/E) and 12 times the earnings before interest, taxes, depreciation, and amortization (EBITDA) on the calendar year 2026 estimates (CY26E).

Goldman Sachs’ analysis suggests that these valuation levels have the potential to decrease if the company’s earnings do not show an upward trend. The firm’s stance implies a cautious outlook on the stock’s future performance, advising investors of the possible downside risks associated with Booz Allen Hamilton’s financial prospects.

In other recent news, Booz Allen Hamilton reported mixed financial results for the fourth quarter of fiscal year 2025. The company’s earnings per share met expectations at $1.61, but revenue fell short, coming in at $2.97 billion against a projected $3.03 billion. This revenue miss was significant, contributing to a 14.43% decline in the company’s premarket stock. Booz Allen Hamilton’s AI business showed robust growth, exceeding 30% and reaching approximately $800 million, while the company plans a 7% headcount reduction in the first quarter of fiscal year 2026.

The firm’s year-end backlog increased by 15% to $37 billion, indicating potential for future growth. UBS analyst Gavin Parsons (NYSE:PSN) maintained a Neutral rating on Booz Allen Hamilton stock, noting the company’s fiscal year 2026 revenue guidance of 0-4% fell short of expectations. Truist Securities also maintained a Hold rating, citing pressures faced by Civil agencies despite growth in the Defense and National Security segments. Meanwhile, Raymond (NSE:RYMD) James downgraded Booz Allen Hamilton’s stock from Outperform to Market Perform, highlighting a slowdown in organic growth and challenges in aligning with current U.S. administration priorities. These developments reflect the company’s mixed performance across its various segments and the challenges it faces moving forward.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.